In the News
Real Clear Policy: Kill the Medical Device Tax
The Daily Caller: The Senate Should Repeal The Medical Device Tax
The U.S. leads the world in medical technology innovation. The medical device excise tax, a 2.3% levy, threatens to stifle American innovation and hinder the ability of industry to develop new life-saving and life-enhancing medical devices. Initially implemented in 2013 as part of the Affordable Care Act, the tax has been suspended twice because policymakers recognized the tax for what it is -- bad policy that will harm patients, health care providers, and the American economy.
If Congress fails to act, the device tax will be reinstated in January 2020. Congress must end the tax once and for all to save and improve patients’ lives and to encourage job growth and innovation. Only with long-term tax relief will the medtech industry be able to make the multi-year investments in R&D and infrastructure necessary to sustain this dynamic innovation ecosystem.